Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01).
Rasmussen LS, Winther SB, Chen IM, Weber B, Ventzel L, Liposits G, Johansen JS, Detlefsen S, Egendal I, Shim S, Christensen S, Pfeiffer P, Ladekarl M. Rasmussen LS, et al. Among authors: liposits g. BMC Cancer. 2023 Jun 16;23(1):552. doi: 10.1186/s12885-023-11035-6. BMC Cancer. 2023. PMID: 37328835 Free PMC article. Clinical Trial.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. Among authors: liposits g. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Twelve ESMO Congress 2022 breakthroughs: practicing oncologists' perceptions and potential application on presented data.
van Halteren HK, Bennouna J, Brasiuniene B, Tomas AJC, Trinidad AMG, Indini A, Liposits G, Pellegrino B, Popovic L, Tan A, Vidra R, Strijbos M; Practising Oncologists Working Group. van Halteren HK, et al. Among authors: liposits g. ESMO Open. 2023 Feb;8(1):100773. doi: 10.1016/j.esmoop.2022.100773. Epub 2023 Jan 10. ESMO Open. 2023. PMID: 36634532 Free PMC article. Review.
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
Kinos S, Hagman H, Halonen P, Soveri LM, O'Reilly M, Pfeiffer P, Frödin JE, Sorbye H, Heervä E, Liposits G, Kallio R, Ålgars A, Ristamäki R, Salminen T, Bärlund M, Shah CH, McDermott R, Röckert R, Flygare P, Kwakman J, Teske A, Punt C, Glimelius B, Österlund P. Kinos S, et al. Among authors: liposits g. Acta Oncol. 2024 May 2;63:248-258. doi: 10.2340/1651-226X.2024.24023. Acta Oncol. 2024. PMID: 38698698 Free article.
Palliative medical cancer treatment of the elderly.
Winther SB, Liposits G, Jørgensen TL, Nielsen D, Giger AW, Pfeiffer P. Winther SB, et al. Among authors: liposits g. Ugeskr Laeger. 2024 Jan 22;186(4):V06230383. doi: 10.61409/V06230383. Ugeskr Laeger. 2024. PMID: 38305323 Free article. Review. Danish.
Angiogenesis inhibitors for metastatic colorectal cancer.
Pfeiffer P, Liposits G, Taarpgaard LS. Pfeiffer P, et al. Among authors: liposits g. Transl Cancer Res. 2023 Dec 31;12(12):3241-3244. doi: 10.21037/tcr-23-1568. Epub 2023 Dec 26. Transl Cancer Res. 2023. PMID: 38192992 Free PMC article. No abstract available.
The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-study.
Liposits G, Winther SB, Ryg J, Skuladottir H, Möller S, Hofsli E, Shah CH, Poulsen LØ, Berglund Å, Qvortrup C, Osterlund P, Glimelius B, Sorbye H, Pfeiffer P. Liposits G, et al. J Geriatr Oncol. 2024 Mar;15(2):101632. doi: 10.1016/j.jgo.2023.101632. Epub 2023 Sep 18. J Geriatr Oncol. 2024. PMID: 37730481 Free article. No abstract available.
41 results